Zee Entertainment Enterprises Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: December 5, 2025, 4:44 am

Competitors of Zee Entertainment Enterprises Ltd

All Competitor Stocks of Zee Entertainment Enterprises Ltd

Quarterly Result

Last Updated: August 1, 2025, 9:05 am

Below is a detailed analysis of the quarterly data for Zee Entertainment Enterprises Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 1,825.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,184.00 Cr. (Mar 2025) to 1,825.00 Cr., marking a decrease of 359.00 Cr..
• For Expenses, as of Jun 2025, the value is 1,586.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1,886.00 Cr. (Mar 2025) to 1,586.00 Cr., marking a decrease of 300.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 298.00 Cr. (Mar 2025) to 239.00 Cr., marking a decrease of 59.00 Cr..
• For OPM %, as of Jun 2025, the value is 13.00%. The value appears to be declining and may need further review. It has decreased from 14.00% (Mar 2025) to 13.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 25.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 25.00 Cr., marking a decrease of 11.00 Cr..
• For Interest, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Depreciation, as of Jun 2025, the value is 59.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 64.00 Cr. (Mar 2025) to 59.00 Cr., marking a decrease of 5.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 197.00 Cr.. The value appears to be declining and may need further review. It has decreased from 262.00 Cr. (Mar 2025) to 197.00 Cr., marking a decrease of 65.00 Cr..
• For Tax %, as of Jun 2025, the value is 27.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 27.00%, marking a decrease of 1.00%.
• For Net Profit, as of Jun 2025, the value is 144.00 Cr.. The value appears to be declining and may need further review. It has decreased from 188.00 Cr. (Mar 2025) to 144.00 Cr., marking a decrease of 44.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 1.50. The value appears to be declining and may need further review. It has decreased from 1.96 (Mar 2025) to 1.50, marking a decrease of 0.46.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 4:07 am

Balance Sheet

Last Updated: December 4, 2025, 2:14 am

Below is a detailed analysis of the balance sheet data for Zee Entertainment Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 96.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 96.00 Cr..
• For Reserves, as of Sep 2025, the value is 11,488.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,437.00 Cr. (Mar 2025) to 11,488.00 Cr., marking an increase of 51.00 Cr..
• For Borrowings, as of Sep 2025, the value is 286.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 321.00 Cr. (Mar 2025) to 286.00 Cr., marking a decrease of 35.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 1,809.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,880.00 Cr. (Mar 2025) to 1,809.00 Cr., marking a decrease of 71.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 13,680.00 Cr.. The value appears to be improving (decreasing). It has decreased from 13,734.00 Cr. (Mar 2025) to 13,680.00 Cr., marking a decrease of 54.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 951.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,005.00 Cr. (Mar 2025) to 951.00 Cr., marking a decrease of 54.00 Cr..
• For CWIP, as of Sep 2025, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Investments, as of Sep 2025, the value is 1,086.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,195.00 Cr. (Mar 2025) to 1,086.00 Cr., marking a decrease of 109.00 Cr..
• For Other Assets, as of Sep 2025, the value is 11,640.00 Cr.. The value appears strong and on an upward trend. It has increased from 11,533.00 Cr. (Mar 2025) to 11,640.00 Cr., marking an increase of 107.00 Cr..
• For Total Assets, as of Sep 2025, the value is 13,680.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13,734.00 Cr. (Mar 2025) to 13,680.00 Cr., marking a decrease of 54.00 Cr..

Notably, the Reserves (11,488.00 Cr.) exceed the Borrowings (286.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Zee Entertainment Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 7.08. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 7.08, marking an increase of 5.61.
• For Diluted EPS (Rs.), as of Mar 25, the value is 7.08. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 7.08, marking an increase of 5.61.
• For Cash EPS (Rs.), as of Mar 25, the value is 9.96. This value is within the healthy range. It has increased from 4.68 (Mar 24) to 9.96, marking an increase of 5.28.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.01. It has increased from 113.14 (Mar 24) to 120.01, marking an increase of 6.87.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 120.01. It has increased from 113.14 (Mar 24) to 120.01, marking an increase of 6.87.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 86.31. It has decreased from 89.88 (Mar 24) to 86.31, marking a decrease of 3.57.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 13.90. This value is within the healthy range. It has increased from 10.83 (Mar 24) to 13.90, marking an increase of 3.07.
• For PBIT / Share (Rs.), as of Mar 25, the value is 11.00. This value is within the healthy range. It has increased from 7.61 (Mar 24) to 11.00, marking an increase of 3.39.
• For PBT / Share (Rs.), as of Mar 25, the value is 9.63. This value is within the healthy range. It has increased from 3.96 (Mar 24) to 9.63, marking an increase of 5.67.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 7.07. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 7.07, marking an increase of 5.60.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 7.07. This value is within the healthy range. It has increased from 1.47 (Mar 24) to 7.07, marking an increase of 5.60.
• For PBDIT Margin (%), as of Mar 25, the value is 16.10. This value is within the healthy range. It has increased from 12.04 (Mar 24) to 16.10, marking an increase of 4.06.
• For PBIT Margin (%), as of Mar 25, the value is 12.74. This value is within the healthy range. It has increased from 8.46 (Mar 24) to 12.74, marking an increase of 4.28.
• For PBT Margin (%), as of Mar 25, the value is 11.16. This value is within the healthy range. It has increased from 4.40 (Mar 24) to 11.16, marking an increase of 6.76.
• For Net Profit Margin (%), as of Mar 25, the value is 8.18. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 8.18, marking an increase of 6.55.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 8.19. This value is within the healthy range. It has increased from 1.63 (Mar 24) to 8.19, marking an increase of 6.56.
• For Return on Networth / Equity (%), as of Mar 25, the value is 5.89. This value is below the healthy minimum of 15. It has increased from 1.30 (Mar 24) to 5.89, marking an increase of 4.59.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.85. This value is below the healthy minimum of 10. It has increased from 6.52 (Mar 24) to 8.85, marking an increase of 2.33.
• For Return On Assets (%), as of Mar 25, the value is 4.94. This value is below the healthy minimum of 5. It has increased from 1.05 (Mar 24) to 4.94, marking an increase of 3.89.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.01. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has increased from 0.00 (Mar 24) to 0.01, marking an increase of 0.01.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.61. It has decreased from 0.63 (Mar 24) to 0.61, marking a decrease of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 6.56. This value exceeds the healthy maximum of 3. It has increased from 5.00 (Mar 24) to 6.56, marking an increase of 1.56.
• For Quick Ratio (X), as of Mar 25, the value is 2.80. This value exceeds the healthy maximum of 2. It has increased from 1.92 (Mar 24) to 2.80, marking an increase of 0.88.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.21. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 1.21, marking an increase of 1.21.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.14. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 14.14, marking an increase of 14.14.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 10.03. This value is below the healthy minimum of 20. It has increased from 0.00 (Mar 24) to 10.03, marking an increase of 10.03.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.86. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 85.86, marking an increase of 85.86.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 89.97. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 89.97, marking an increase of 89.97.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 40.84. This value is within the healthy range. It has increased from 14.43 (Mar 24) to 40.84, marking an increase of 26.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 25.02. This value is within the healthy range. It has increased from 7.62 (Mar 24) to 25.02, marking an increase of 17.40.
• For Enterprise Value (Cr.), as of Mar 25, the value is 8,359.61. It has decreased from 12,141.37 (Mar 24) to 8,359.61, marking a decrease of 3,781.76.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.01. This value is within the healthy range. It has decreased from 1.41 (Mar 24) to 1.01, marking a decrease of 0.40.
• For EV / EBITDA (X), as of Mar 25, the value is 6.26. This value is within the healthy range. It has decreased from 11.67 (Mar 24) to 6.26, marking a decrease of 5.41.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 1.14, marking a decrease of 0.40.
• For Retention Ratios (%), as of Mar 25, the value is 85.85. This value exceeds the healthy maximum of 70. It has increased from 0.00 (Mar 24) to 85.85, marking an increase of 85.85.
• For Price / BV (X), as of Mar 25, the value is 0.81. This value is below the healthy minimum of 1. It has decreased from 1.23 (Mar 24) to 0.81, marking a decrease of 0.42.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.14. This value is within the healthy range. It has decreased from 1.54 (Mar 24) to 1.14, marking a decrease of 0.40.
• For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.07, marking an increase of 0.06.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness